George Sellers
Stock Analyst at Stephens & Co.
(0.72)
# 1,631
Out of 4,650 analysts
57
Total ratings
23.4%
Success rate
-24.08%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUTR Cutera | Maintains: Overweight | $10 → $5 | $0.67 | +648.50% | 11 | Aug 9, 2024 | |
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $44.76 | +51.92% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $236.63 | +22.55% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $45.66 | +27.03% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $126.24 | +41.00% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $24.66 | -2.68% | 6 | May 29, 2024 | |
| FNA Paragon 28 | Reiterates: Overweight | $18 | $4.84 | +271.90% | 3 | Apr 5, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $41.17 | +74.88% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $1.27 | +293.70% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $4.84 | +416.53% | 4 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $57 | $30.69 | +85.73% | 6 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $71 | $134.08 | -47.05% | 4 | May 8, 2023 |
Cutera
Aug 9, 2024
Maintains: Overweight
Price Target: $10 → $5
Current: $0.67
Upside: +648.50%
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $44.76
Upside: +51.92%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $236.63
Upside: +22.55%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $45.66
Upside: +27.03%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $126.24
Upside: +41.00%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $24.66
Upside: -2.68%
Paragon 28
Apr 5, 2024
Reiterates: Overweight
Price Target: $18
Current: $4.84
Upside: +271.90%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $41.17
Upside: +74.88%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $1.27
Upside: +293.70%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $4.84
Upside: +416.53%
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $30.69
Upside: +85.73%
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $134.08
Upside: -47.05%